S&P 500   3,247.05 (-1.47%)
DOW   28,563.29 (-1.47%)
QQQ   218.36 (-1.95%)
AAPL   309.13 (-2.89%)
FB   214.63 (-1.52%)
MSFT   162.02 (-1.83%)
GOOGL   1,431.06 (-2.39%)
AMZN   1,828.04 (-1.80%)
CGC   22.04 (-2.69%)
NVDA   239.06 (-4.56%)
BABA   205.27 (-3.97%)
MU   55.24 (-4.36%)
GE   11.42 (-2.48%)
AMD   48.81 (-3.06%)
T   38.26 (-0.62%)
ACB   1.92 (-3.53%)
F   8.82 (-2.11%)
NFLX   349.50 (-1.04%)
PRI   120.10 (-1.98%)
BAC   32.92 (-1.85%)
DIS   137.59 (-1.78%)
GILD   62.89 (-0.41%)
S&P 500   3,247.05 (-1.47%)
DOW   28,563.29 (-1.47%)
QQQ   218.36 (-1.95%)
AAPL   309.13 (-2.89%)
FB   214.63 (-1.52%)
MSFT   162.02 (-1.83%)
GOOGL   1,431.06 (-2.39%)
AMZN   1,828.04 (-1.80%)
CGC   22.04 (-2.69%)
NVDA   239.06 (-4.56%)
BABA   205.27 (-3.97%)
MU   55.24 (-4.36%)
GE   11.42 (-2.48%)
AMD   48.81 (-3.06%)
T   38.26 (-0.62%)
ACB   1.92 (-3.53%)
F   8.82 (-2.11%)
NFLX   349.50 (-1.04%)
PRI   120.10 (-1.98%)
BAC   32.92 (-1.85%)
DIS   137.59 (-1.78%)
GILD   62.89 (-0.41%)
S&P 500   3,247.05 (-1.47%)
DOW   28,563.29 (-1.47%)
QQQ   218.36 (-1.95%)
AAPL   309.13 (-2.89%)
FB   214.63 (-1.52%)
MSFT   162.02 (-1.83%)
GOOGL   1,431.06 (-2.39%)
AMZN   1,828.04 (-1.80%)
CGC   22.04 (-2.69%)
NVDA   239.06 (-4.56%)
BABA   205.27 (-3.97%)
MU   55.24 (-4.36%)
GE   11.42 (-2.48%)
AMD   48.81 (-3.06%)
T   38.26 (-0.62%)
ACB   1.92 (-3.53%)
F   8.82 (-2.11%)
NFLX   349.50 (-1.04%)
PRI   120.10 (-1.98%)
BAC   32.92 (-1.85%)
DIS   137.59 (-1.78%)
GILD   62.89 (-0.41%)
S&P 500   3,247.05 (-1.47%)
DOW   28,563.29 (-1.47%)
QQQ   218.36 (-1.95%)
AAPL   309.13 (-2.89%)
FB   214.63 (-1.52%)
MSFT   162.02 (-1.83%)
GOOGL   1,431.06 (-2.39%)
AMZN   1,828.04 (-1.80%)
CGC   22.04 (-2.69%)
NVDA   239.06 (-4.56%)
BABA   205.27 (-3.97%)
MU   55.24 (-4.36%)
GE   11.42 (-2.48%)
AMD   48.81 (-3.06%)
T   38.26 (-0.62%)
ACB   1.92 (-3.53%)
F   8.82 (-2.11%)
NFLX   349.50 (-1.04%)
PRI   120.10 (-1.98%)
BAC   32.92 (-1.85%)
DIS   137.59 (-1.78%)
GILD   62.89 (-0.41%)
Log in

NGM Biopharmaceuticals Insider Trades (NYSE:NGM)

$17.34
-0.11 (-0.63 %)
(As of 01/27/2020 09:45 AM ET)
Add
Today's Range
$17.00
Now: $17.34
$17.46
50-Day Range
$16.66
MA: $18.53
$20.28
52-Week Range
$8.81
Now: $17.34
$20.50
Volume17,328 shs
Average Volume177,706 shs
Market Capitalization$1.16 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Insider Trades

NGM Biopharmaceuticals (NYSE:NGM) Insider Buying and Selling Activity

Insider Buying and Selling by Quarter

NGM Biopharmaceuticals (NYSE NGM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/9/2020Jin-Long ChenInsiderSell18,641$17.95$334,605.951,012,783  
1/7/2020Jin-Long ChenInsiderSell16,090$18.20$292,838.001,012,783  
11/11/2019Peter SvennilsonDirectorBuy15$12.00$180.0020,000  
11/4/2019Jin-Long ChenInsiderSell50,765$12.67$643,192.55
11/4/2019Peter SvennilsonDirectorBuy8,409$13.01$109,401.09
10/23/2019Peter SvennilsonDirectorBuy4,387$13.54$59,399.98
10/21/2019Group L P ColumnMajor ShareholderSell30,926$77.72$2,403,568.72
10/21/2019Peter SvennilsonDirectorBuy84,939$11.75$998,033.25
10/16/2019David V GoeddelDirectorBuy11,000$3.10$34,100.00
10/16/2019Group L P ColumnMajor ShareholderBuy103,000$10.87$1,119,610.00
10/14/2019Group L P ColumnMajor ShareholderSell20,000$1.41$28,200.00
10/11/2019Group L P ColumnMajor ShareholderBuy53,172$10.38$551,925.36
8/9/2019Group L P ColumnMajor ShareholderBuy224,664$14.00$3,145,296.00  
8/6/2019David V GoeddelDirectorBuy6,134$13.98$85,753.32  
8/2/2019Group L P ColumnMajor ShareholderBuy4,382$13.98$61,260.36  
7/30/2019Peter SvennilsonDirectorBuy28,056$13.68$383,806.08  
7/26/2019David V GoeddelDirectorBuy89,866$13.49$1,212,292.34  
7/23/2019Group L P ColumnMajor ShareholderBuy67,742$13.49$913,839.58  
7/16/2019Group L P ColumnMajor ShareholderBuy20,088$13.72$275,607.36  
7/12/2019Group L P ColumnMajor ShareholderBuy31,884$13.88$442,549.92  
6/24/2019Group L P ColumnMajor ShareholderBuy12,240$13.78$168,667.20  
6/21/2019Group L P ColumnMajor ShareholderBuy34,377$13.90$477,840.30  
6/14/2019Peter SvennilsonDirectorBuy29,760$14.05$418,128.00  
6/11/2019Group L P ColumnMajor ShareholderBuy23,500$13.74$322,890.00  
6/6/2019Group L P ColumnMajor ShareholderBuy25,200$13.40$337,680.00  
5/20/2019Group L P ColumnMajor ShareholderBuy50,000$13.50$675,000.00  
5/10/2019Group L P ColumnMajor ShareholderBuy17,923$13.85$248,233.55  
5/7/2019Peter SvennilsonDirectorBuy57,000$14.10$803,700.00  
4/8/2019Merck & Co., Inc.Major ShareholderBuy4,121,683$16.00$65,946,928.00  
4/8/2019Suzanne Sawochka HooperDirectorBuy7,000$16.00$112,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Featured Article: Current Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel